About the National Chlamydia Coalition

Posted on

The National Chlamydia Coalition (NCC) was formed in 2008 to address the high burden of chlamydia in adolescents and young adults by promoting equal access to comprehensive and quality health services. Our membership comprises national nonprofit organizations, healthcare professional associations, advocacy groups, health insurers, and local, state, and federal government representatives.

Presentations from the 2020 STD Prevention Conference

Posted on
2020 STD Prevention Conference Logo

Click on the title of the presentation below to watch an archived video. Pelvic Inflammatory Disease Biomarkers for Diagnosing PID: Where Are We? Sharon Hillier, PhD University of Pittsburgh School of Medicine The Epidemiology of Pelvic Inflammatory Disease in the United States Kristen Kreisel, PhD Centers for Disease Control and Prevention Does Screening for Chlamydia […]

Strategies to Improve Retesting Rates

Posted on

Identifying Patients for Retesting One practice-based factor that leads to low retesting rates is lack of a consistent method for identifying patients due for retesting when they visit the office for another reason. To prevent missed opportunities for retesting, it is recommended to institute system-level interventions, such as paper or electronic chart prompts (“pop-ups”), to […]

What should I know about screening males?

Posted on

There is no recommendation to routinely screen for chlamydia among heterosexual males. But, screening sexually active adolescent and young adult men should be considered in clinical settings with a high prevalence of chlamydia (e.g., adolescent clinics, correctional facilities, and sexually transmitted disease clinics) or in populations with high burden of infection (e.g., gay, bisexual, and […]

Clinical Practice Tools

Posted on

Risk Assessment, Screening and Treatment CDC’s Sexually Transmitted Infections (STI) Treatment Guidelines, 2021 Provides current evidence-based prevention, diagnostic and treatment recommendations. The recommendations are intended to be a source for clinical guidance. Healthcare providers should always assess patients based on their clinical circumstances and local burden. Recommendations for Providing Quality STD Clinical Services (STD QCS) […]

Presentations from the 2018 STD Prevention Conference

Posted on
2018 STD Prevention Conference

Click on the title of the presentations below to watch an archived video from the conference. Debate: Should Health Departments Stop Active Surveillance and Partner Services for Chlamydia? PRO Joan Chow, DrPH, MPH California Department of Public Health, CA CON William Miller, MD, PhD The Ohio State University, OH The Population-Level Impact of Screening Women […]

What specimen source/type should I use for screening?

Posted on
man holding a urine specimen for screening

The Centers for Disease Control and Prevention (CDC) laboratory recommendations for chlamydia screening that were published April 2014 state that a vaginal swab is the preferred specimen type for women. It can either be clinician-collected or self-collected. Other acceptable sources are a cervical swab or a first-pass urine sample. For men, the recommended specimen is […]

Testing for Chlamydia in Mobile Settings

Posted on

Commentary by Ellen Pittman, Lea E. Widdice, MD, University of Cincinnati Screening, treatment, and education to prevent future infections among populations at risk for sexually transmitted infections (STIs) are critical components of public health efforts to control STIs, including chlamydia. Typically, chlamydia screening is accessible only in traditional health care settings, such as medical provider’s […]